Qing Song Health Co.,Ltd. (TPE:6931)
35.55
0.00 (0.00%)
Nov 13, 2026, 1:30 PM CST
Qing Song Health Revenue
Qing Song Health had revenue of 335.36M TWD in the quarter ending September 30, 2026, with 17.88% growth. This brings the company's total for the last twelve months to 1.26B, up 16.75% year-over-year. In the year 2025, Qing Song Health had annual revenue of 1.12B with 14.16% growth. That makes Qing Song Health the 29,821st largest company in the world by revenue and 1,463rd in Taiwan.
Revenue (ttm)
1.26B
Revenue Growth
+16.75%
P/S Ratio
1.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.35B
Revenue by Segment
- Long-Term Care Services 1.06B 90.0%
- Management Consulting 61.21M 5.2%
- Renovation 56.23M 4.8%
Fiscal year ended Dec 31, 2025 See the full Qing Song Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 139.14M | 14.16% |
| Dec 31, 2024 | 982.56M | 113.90M | 13.11% |
| Dec 31, 2023 | 868.66M | 231.98M | 36.43% |
| Dec 31, 2022 | 636.69M | 279.15M | 78.08% |
| Dec 31, 2021 | 357.54M | 117.30M | 48.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 24.62B |
| ShareHope Medicine | 4.61B |
| Wellell | 2.56B |
| TSH Biopharm Corporation | 1.53B |
| BIONET | 1.32B |
| Chunghwa Chemical Synthesis & Biotech | 934.29M |
| GlycoNex Incorporation | 19.51M |
| Caliway Biopharmaceuticals | 15.98M |